312.

Edwards PJ, Morwood K. Pharmaceutical compositions against gastric disorders containing bacteriocins. PCT Int. Appl. WO 92 18,143 (Cl. A61K37/02), 29 Oct 1992, GB Appl. 91/8,129, 15 Apr 1991; 15 pp. (CA) [An oral compn. for the treatment of gastric disorders assocd. with Helicobacter pylori comprises a bacteriocin, substances providing a sustained drug release (mucoadherent or bioadhesive substances), chelating agents, or surfactants. Tablets contg. ambicin N 500, Sucralfate 500, Na CM-starch glycollate 30, Mg stearate 20, silica 12, and microcryst. cellulose to 1500 mg/each were prepd. by compression.]

Gordon Research Institute / Reference Material

Gordon Research Institute    Dr. Garry F. Gordon MD DO MD(H)
600 N Beeline Hwy, Suite B, Payson, AZ 85541
Phone: 928-472-4263    Fax: 928-474-3819
Email Dr.Gordon